ArticleSubstance abuse treatment, prevention, and policy2021
Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre.
Article in Substance abuse treatment, prevention, and policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06858527 (Adults With Attention Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment), which is not on this map. Cited by 28 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Adults With Attention Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment: Effectiveness and Feasibility
Who cites it
28 citing papers in PubMed, 5 syntheses or guidelines pooled it, 93 citations in OpenAlex.
- Risk and protective factors for relapse after residential substance use treatment: a systematic review and meta-analysis.BMC psychiatry · 2026Pooled it
- Financial Incentives for Substance Abstinence: A Systematic Review and Meta-analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025Pooled it
- Treatment outcomes for substance use disorders across the African continent: a systematic review.BMC psychology · 2025Pooled it
- Efficacy of cannabidiol alone or in combination with Δ-9-tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence.Addiction (Abingdon, England) · 2025Pooled it
- Relapse and associated factors among psychiatric patients in Africa: a systematic review and meta-analysis.BMC psychiatry · 2025Pooled it
- Life-skills training program: its effect on self-efficacy among patients with substance use disorders.BMC psychology · 2026Trial
- Perceptions of Psychiatric Nurses on Substance Use Relapse Prevention Among the Youth- An Exploratory Qualitative Study.Nursing open · 2026Article
- A study on the psychometric properties of the Arabic-translated connor-davidson resilience scale (CD-RISC-25) and Arabic-translated stimulant relapse risk scale (SRRS) in Emirati patients with substance use disorder.International journal of mental health systems · 2026Article
- A phenomenological analysis of relapse among adults with substance abuse.Scientific reports · 2026Article
- Perceptions of Youth Substance Users on Substance Use Relapse Prevention: A Qualitative Study in Lobatse, Botswana.International journal of environmental research and public health · 2025Article
- Prevalence, Predictors, and Moderators of Relapse in Severe Mental Disorders: Evidence from Ndera Neuropsychiatric Teaching Hospital, Rwanda.Rwanda journal of medicine and health sciences · 2025Article
- Exploration of Effective Substance Use Relapse Prevention Programmes for the Youth: An Integrative Literature Review.Journal of psychiatric and mental health nursing · 2025Review
- Repeated prefrontal tDCS improves cognitive emotion regulation and readiness for treatment in substance use disorder: A randomized sham-controlled study.Addictive behaviors reports · 2025Article
- The Resilience on Amphetamine Relapse Youth Scale: development and psychometric properties.Scientific reports · 2025Article
- A substance use relapse prevention programme for youth with substance use problems in Botswana.Health SA = SA Gesondheid · 2025Article
- Prevalence of alcohol and substance use relapse in forensic inpatients with substance use disorders in Germany.Frontiers in psychiatry · 2025Article
- A smartphone app-based mindfulness intervention to enhance recovery from substance use disorders: Protocol for a pilot feasibility randomized controlled trial.Contemporary clinical trials communications · 2024Article
- Maltreatment, resilience, and sexual relationship power in a sample of justice-involved women with opioid use disorder.Journal of traumatic stress · 2024Article
- The phenotype of recovery XI: associations of sleep quality and perceived stress with discounting and quality of life in substance use recovery.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024Article
- Cognitive training interventions for substance use disorders: what they really offer?Frontiers in public health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRelapse to substance use after successful detoxication and rehabilitation is a public health concern worldwide. Forty to sixty percent of persons in general relapsed after completing detoxication and rehabilitation treatments. Although substance use remains a burden in Rwanda, very little is known about relapse among people with substance use disorder (SUD). Hence, this study aimed to examine prevalence and the factors associated with relapse to substance use at Icyizere Psychotherapeutic Centre (IPC), Rwanda.
methodsRetrospective, cross-sectional survey was conducted among 391 patients with SUD at IPC. Multiple logistic regression models using STATA version 13 were used to determine the factors associated with relapse among the patients with SUD.
resultsMajority (84.1 %) of the participants were males. More than half (54.1 %) of them were aged between 18 and 30 years with the age average of 33 years (SD = 11.9 years). The results showed a higher prevalence of relapse among patients with SUD (59.9 %). The multivariate analyses indicated that people with SUD living only with their mothers had a greater risk of relapse compared to those with both biological parents [OR = 1.9, 95 % CI (1.02-3.6), p = 0.04]. Patients that were hospitalized between one to three months were more likely (11.2 times) to relapse after treatments compared to those who spent more than three months in hospitalization [OR = 9.2, 95 % CI (1.1-77.6), p = 0.02]. Furthermore, people that used more than two substances had 1.5 greater risk to relapse than those who consumed one substance. Participants were more likely to relapse if they lived with their peers [OR = 2.4, 95 % CI: (1.2-7.8), p = 0.01] or if they lived in a family with conflicts [OR = 2.1, 95 % CI (1.05-9.7), p = 0.02].
conclusionsThis study is conducted at one institution caring for patients with SUD. The prevalence was 59.9 %. Future studies are recommended to investigate the effectiveness of the existing relapse prevention programs in order to adjust prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.